TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,428,138 | +99.8% | 1,135,092 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $6,719,745 | +48.2% | 1,135,092 | +6.4% | 0.00% | +100.0% |
| Q2 2022 | $4,533,046 | -53.1% | 1,066,599 | +5.0% | 0.00% | -50.0% |
| Q1 2022 | $9,656,663 | -50.3% | 1,015,422 | -0.7% | 0.00% | -50.0% |
| Q4 2021 | $19,436,000 | -29.2% | 1,022,922 | +24.0% | 0.00% | -33.3% |
| Q3 2021 | $27,450,000 | -36.7% | 824,824 | -26.3% | 0.01% | -33.3% |
| Q2 2021 | $43,398,000 | -16.0% | 1,118,783 | +4.4% | 0.01% | -25.0% |
| Q1 2021 | $51,663,000 | -22.1% | 1,071,846 | -16.0% | 0.01% | -20.0% |
| Q4 2020 | $66,351,000 | +96.7% | 1,275,493 | +1.2% | 0.02% | +66.7% |
| Q3 2020 | $33,729,000 | +8548.5% | 1,260,410 | +6202.0% | 0.01% | – |
| Q2 2020 | $390,000 | -51.5% | 20,000 | -80.0% | 0.00% | – |
| Q1 2019 | $804,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |